SkinVision

Innovation Type: Patient Self-management

Speciality:

Innovation Origin: NHS Innovator Accelerator (NIA)

An app empowering people to monitor their skin for early signs of skin cancer

SkinVision's CE certified app empowers individuals to monitor their skin lesions for the early signs of skin cancer. The user takes a picture of their skin spots and within 30 seconds they receive a risk indication (low-medium-high). In the case of a high-risk rating, the user will receive advice from SkinVision's team, including dermatologists, within 48 hours on next steps to take.

The accuracy of this service has been tested in clinical studies. The overall sensitivity of the algorithm in recognising skin cancer (melanoma, BCC, SCC and pre-malignant stages) is 95%; in line with experienced dermatologists.

For more information, please visit: https://nhsaccelerator.com/innovation/skinvision/